SHELBI NOLAN: Open Payments
NPI 1497473029 · IRVINE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 16 payments from 11 companies in 2025. Trend: 2023 $263 · 2024 $278 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 4 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Novo Nordisk Inc | 1 | $28 |
| Gilead Sciences, Inc. | 1 | $28 |
| Amgen Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| ABBVIE INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
Products named: Haegarda, Kerendia, Ozempic, OTEZLA, MOUNJARO, VRAYLAR, TRELEGY ELLIPTA, REXULTI.
Industry payments across KY — which companies pay providers there.
